Urolog. pro Praxi, 2010; 11(5): 234-240

Urinary tract infections in women - possibilities of differentiated approach in treatment and prevention

MUDr.Jiří Kladenský
Urologická ambulance, Dům zdraví, Brno

Urinary tract infections (UTIs) are among the most urgent health problems for which women in working age see their physician (whether the

general practitioner, urologist or gynecologist). The most common manifestation of UTIs in women is acute uncomplicated cystitis the

diagnosis and treatment of which is usually straightforward. When selecting an appropriate antimicrobial agent, it is advisable to consider

its pharmacokinetics, expected spectrum of efficacy and effect on the vaginal flora. Short-term therapy of three to five days is

preferred. In women with recurrent cystitides, it is necessary, in addition to performing comprehensive urological examination to rule

out functional or anatomic abnormalities, to perform urine culture and targeted treatment according to sensitivity. The review article

presents differentiated options of treatment and prevention of recurrent infections with both antimicrobial agents and regimen measures

as well as preparations not included in the group of antimicrobial agents; however, when correctly indicated, their administration

may bring long-term relief to these women. The article also deals with complicated infections in women and asymptomatic bacteriuria

in elderly women.

Keywords: acute uncomplicated cystitis, recurrent cystitis, complicated urinary tract infection, asymptomatic bacteriuria

Published: October 22, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kladenský J. Urinary tract infections in women - possibilities of differentiated approach in treatment and prevention. Urol. praxi. 2010;11(5):234-240.
Download citation

References

  1. Lipsky BA. Urinary tract infections in men. Ann Intern Med, 1989; 138-148. Go to original source... Go to PubMed...
  2. Nicolle LE. Managing recurrent urinary tract infections in women. Womens health (Lond Engl), 2005; 1(1): 39-50. Go to original source... Go to PubMed...
  3. Schappert SM. National ambulatory medical survey: 1990 summary. Advance data from vital and health statistics. No. 213, 1992, Hyattsville, Maryland, USA, National Center for Health Statistics.
  4. Kladenský J, Pacík D. Infekce dolních močových cest u žen. Praktická gynekologie, 2001; 5: 43-45.
  5. Bartoníčková K. Uroinfekce. Praha: Galén, 2000: 42-49.
  6. Kladenský J. Infekce dolních močových cest. Diagnóza, 2000; 1: 6.
  7. Hooton TM, Stamm WE. Management of acute uncomplicated urinary tract infections in adults. Med Clin North Am, 1991; 75: 339-357. Go to original source... Go to PubMed...
  8. Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rew Infet Dis, 1990; 12: 456-467. Go to original source... Go to PubMed...
  9. Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med, 2007; 167(20): 2207-2212. Go to original source... Go to PubMed...
  10. Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, Lavi I, Stamm W. Empiric use of trimethoprim- sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX- resistant uropathogens. Clin Infect Dis, 2002; 34(9): 1165-1169. Go to original source... Go to PubMed...
  11. Kladenský J, Toršová V, Chmelařová E. Přínos nifuratelu pro léčbu akutních nekomplikovaných uroinfekcí. Urolog. pro praxi, 2006; 7: 109-110.
  12. Matera MG. Pharmacologic characteristics of prulifloxacin. Pulmonary Pharmacology and Therapeutics, 2006; 19: 20-29. Go to original source... Go to PubMed...
  13. Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Rezistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol, 2008; 54(5): 1164-1175. Go to original source... Go to PubMed...
  14. Kladenský J, Pacík D. Infekce močových cest u dospělých. Forum medicinae, 2001; 3: 23.
  15. Hooton TM. Reccurent urinary tract infection in women. Int J Antimicrob Agents, 2001; 17(4): 259-268. Go to original source... Go to PubMed...
  16. Finger G, Landau D. Pathogenesis of urinary tract infections with normal female anatomy. Lancet Infect Dis, 2004; 4(10): 631-635. Go to original source... Go to PubMed...
  17. Kladenský J, Pacík D, Čermák A. Nifuratel tbl. v léčbě akutní nekomplikované uroinfekce. Česká urologie, 1998; 5: 8-10.
  18. Reid G, Chan RC, Bruce AW, Costerton JW. Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain. Infect Immun, 1985; 49(2): 320-324. Go to original source... Go to PubMed...
  19. Gupta K, Chou M, Howell A, Wobbe C, Grady R, Stapteton A. Cranberry products inhibit adherence of P-fimbriated E. coli to ptimary cultured bladder and vaginal epithepial cells. J Urol, 2007; 177(6): 2357-2360. Go to original source... Go to PubMed...
  20. Raz R, Stamm WE. Protocol of diagnosis of urinary tract infection: Reconsidering the criterion for significant bacteriuria. Urology, 1988; 32: 6-12.
  21. Ronald AR, Patullo AL. The natural history of urinary infections in adults. Med Clin North Am, 1991; 75: 299-312. Go to original source... Go to PubMed...
  22. Kladenský J, Pacík D. Nespecifické infekce dospělých. Postgraduální medicína, 2000; 2: 137.
  23. Nicolle LE, Ronald AR. Recurrent urinary tract infection in adult women. Diagnosis and treatment. Infect Dis Clin North Am, 1987; 1: 793-806. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.